Human medicinal products | | SPC PL | | Veterinary medicinal
products | SPC PL | | Herbal medicinal products | | SPC PL | | Name of the medicinal
product |
| |
|
|
Package Leaflets (PL) for Human medicinal products
The package leaflet (PL) provides users with information about the medicinal product and its correct use. The package leaflets contain instructions in both Finnish and Swedish.
The package leaflets can be searched from alphabetical list, with the name, marketing authorisation number and the Anatomical Therapeutic Chemical, i.e. ATC Code of the Summary of Product Characteristics, SPC.
The package leaflets processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA.
Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website.
Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.
The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.
Product Information Leaflets 361 - 390 of 457 |
|
|
SPC | Status for supply | Name of the medicinal product |
SPC
|
Itsehoito
|
Aspirin zipp 500 mg rakeet PL 2023-11-10
|
SPC
|
Resepti
|
Atacand 4 mg, 8 mg, 16 mg, 32 mg tabletti PL 2023-11-06
|
SPC
|
Resepti
|
Atacand Plus 8 mg-12.5 mg, 16 mg-12.5 mg, 32 mg-12.5 mg, 32 mg-25 mg tabletti PL 2023-11-06
|
SPC
|
Resepti
|
Atarax 2 mg-ml siirappi PL 2023-02-20
|
SPC
|
Resepti
|
Atarax 25 mg tabletti PL 2023-12-20
|
|
|
European Medicines Agency's website: Atazanavir Krka - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Atazanavir Mylan - EMA: EPAR PI
Finnish Swedish
|
SPC
|
Resepti
|
Atazanavir Stada 200 mg, 300 mg kapseli, kova PL 2023-12-14
|
|
|
European Medicines Agency's website: Atectura Breezhaler - EMA: EPAR PI
Finnish Swedish
|
SPC
|
Resepti
|
Atenativ 500 ky, 1000 ky infuusiokuiva-aine ja liuotin PL 2019-05-13
|
SPC
|
Resepti
|
Atenblock 25 mg, 50 mg, 100 mg tabletti, kalvopäällysteinen PL 2023-11-24
|
SPC
|
Resepti
|
Atenolol Sandoz 25 mg, 50 mg tabletti PL 2021-04-07
|
SPC
|
Resepti
|
Atenolol Sandoz 25 mg, 50 mg tabletti PL 2021-04-07
|
SPC
|
Resepti
|
Atgam 50 mg-ml infuusiokonsentraatti, liuosta varten PL 2023-10-03
|
SPC
|
Resepti
|
Atomoxetin Orion 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg, 100 mg kapseli, kova PL 2020-01-31
|
SPC
|
Resepti
|
Atomoxetine Accord 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg, 100 mg kapseli, kova PL 2019-03-27
|
SPC
|
Resepti
|
Atomoxetine Stada 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, 100mg kapseli, kova PL 2022-05-31
|
SPC
|
Resepti
|
Atorbir 10 mg, 20 mg, 40 mg tabletti, kalvopäällysteinen PL 2024-01-09
|
SPC
|
Resepti
|
Atorvastatin Accord 10 mg, 20 mg, 40 mg, 80 mg tabletti, kalvopäällysteinen PL 2023-03-21
|
SPC
|
Resepti
|
Atorvastatin Krka 10 mg, 20 mg, 40 mg tabletti, kalvopäällysteinen PL 2023-03-08
|
SPC
|
Resepti
|
Atorvastatin Krka 80 mg tabletti, kalvopäällysteinen PL 2023-03-08
|
SPC
|
Resepti
|
Atorvastatin Orion 10 mg, 20 mg, 40 mg, 80 mg tabletti, kalvopäällysteinen PL 2023-09-25
|
SPC
|
Resepti
|
Atorvastatin Orion Pharma 10 mg, 20 mg, 40 mg, 80 mg tabletti, kalvopäällysteinen PL 2023-03-07
|
SPC
|
Resepti
|
Atorvastatin ratiopharm 10 mg, 20 mg, 40 mg, 80 mg tabletti, kalvopäällysteinen PL 2023-03-22
|
SPC
|
Resepti
|
Atorvastatin Viatris 10 mg, 20 mg, 40 mg, 80 mg tabletti, kalvopäällysteinen PL 2023-11-01
|
SPC
|
Resepti
|
Atosiban Accord 37.5 mg - 5 ml infuusiokonsentraatti, liuosta varten PL 2022-05-27
|
SPC
|
Resepti
|
Atosiban Accord 6,75 mg injektioneste, liuos esitäytetty ruisku PL 2022-05-26
|
SPC
|
Resepti
|
Atosiban Ever Pharma 37,5 mg / 5 ml infuusiokonsentraatti, liuosta varten, PL 2023-07-07.doc
|
SPC
|
Resepti
|
Atosiban EVER pharma 6,75 mg-0,9 ml injektioneste, liuos PL 2023-07-07
|
SPC
|
Resepti
|
Atosiban Ever Pharma 75 mg / 10 ml infuusiokonsentraatti, liuosta varten, PL 2023-07-07.doc
|
|
| |